We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Consortium to Study the Genetics of Lead Pollution in India

By Labmedica staff writers
Posted on 09 Feb 2007
Consortium to Study the Genetics of Lead Pollution in India
A consortium has been formed to study how genetics and environmental lead pollution interact to affect the intellectual and behavioral development of children in India.
Research groups from two American universities, Harvard University (Boston, MA, USA) and the University of Michigan (Ann Arbor, USA) are working with the biotechnology company Bioserve (Laurel, MD, USA; and Hyderabad, India) on this three-year study. More...
BioServe, which has state-of-the-art laboratory facilities in India, will undertake DNA purification and genotyping on tissue samples collected from 750 school children in Chennai (formerly Madras), India who have been exposed to lead pollutants.
The goal is to determine how individual genetic makeup may modify the neurobehavioral impact of lead exposure and to relate these findings to how lead exposure affects both visual-spatial-motor skills and aggressive behavior.
"This study represents a cutting edge research collaboration that will gain insights into a global environmental health problem,” said Dr. Howard Hu, professor of environmental medicine at the University of Michigan. "Understanding the interrelationship of environmental hazards, genetics, and health will provide the information that is needed to formulate regulatory policies, prioritize public health controls, and educate the medical community and the public on how best to mitigate particular environmental exposures.”
Rama Modali, chief executive officer of BioServe, said, "We are excited to play an important role in this landmark health study. Our genotyping studies will contribute to the Indian and international biomedical communities' further understanding of the dynamics between lead exposure and chronic diseases, as well as genetic polymorphisms that increase the risk of environmentally induced disease.”



Related Links:
University of Michigan
Harvard University
Bioserve

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.